• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Antares Pharma Inc. (ATRS)

    -NasdaqCM
    2.63 0.03(1.15%) Dec 19, 4:00PM EST
    Add to Portfolio
    Prev Close:2.60
    Open:2.63
    Bid:N/A
    Ask:3.13 x 2000
    1y Target Est:5.30
    Beta:2.24
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:2.55 - 2.66
    52wk Range:1.82 - 5.01
    Volume:1,857,607
    Avg Vol (3m):1,029,780
    Market Cap:346.33M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ┬╗ More Headlines for ATRS

    Comparison

    Symbol% ChgMkt Cap
    ATRSUp 1.15%346.33M
    BDX26.84B
    BJCT3.08M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.99
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback